Parsing out the genetic underpinnings of depression remains a challenge for researchers, despite the rise in the number of studies focusing on the human genome, the authors of a new…
Read More
Genelex is excited to announce the next chapter in the company’s ongoing mission to improve patient care and reduce adverse drug events. Genelex is unveiling five new panels and 17…
Read More
An international survey of more than 10,000 adults age 65 or older has found that more Americans had multiple chronic conditions and took four or more prescription drugs than their…
Read More
Recurrent falls were more than twice as common in elderly people suffering from pain than those who were not, according to the results of a recent study. The article, published…
Read More
By Rachel Sass, PharmD Should providers increase the clopidogrel dose in patients with decreased functioning CYP2C19 enzymes? Clopidogrel (Plavix) is one of the most well studied medications in pharmacogenetics. Clopidogrel…
Read More
A genomic research project funded by the National Institutes of Health (NIH) dedicated to finding which genetic variants are most relevant to patient care has launched a registry where people…
Read More
November is diabetes awareness month in the U.S., a time to learn more about a disease that affects an estimated 30 million American children and adults. According to data from…
Read More
A new meta-analysis of clinical trials scrutinizing warfarin dosing methods found that warfarin treatment guided by individual genotypes reduced instances of serious bleeding by more than half compared to standard…
Read More
about one in 10 Americans aged 12 and older takes antidepressant medications. The majority of these drugs are metabolized by the body’s highly genetically variable CYP2D6 and CYP2C19 pathways. Response…
Read More
As cardiopulmonologist Mark Pamer, DO, goes about his day at his South Florida practice, one adage from medical school that sticks in his mind is: “All that wheezes is not asthma.” “, we probably all heard…
Read More
